The White House on Thursday announced that it has finalized negotiations with the manufacturers of the 10 drugs selected for the first round of drug price negotiation under the Biden Administration’s Inflation Reduction Act of 2022 (IRA), which the Administration said will save $1.5 billion in out-of-pocket costs for prescription drugs for people on Medicare and will save Medicare $6 billion “in the first year alone.”
Recent Posts
- Stewart Defends Hands-On Approach as Squires Confirmation Looms
- Former USPTO Solicitor Urges Squires Confirmation, Accuses Acting Director of Overreach
- Other Barks & Bites for Friday, September 12: Novartis Loses Challenge to IRA Drug Price Negotiation Program; Lutnick Wants a Share of University IP Licensing; and EUIPO Announces First Copyright Conference
- Government Taking a Cut of University Royalties Would Threaten Bayh-Dole’s ROI
- Conservatives Appeal to Lutnick’s Inventor Roots in Urging Him to Drop ‘Patent Tax’ Proposal